BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21256580)

  • 21. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
    Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
    Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of colorectal anastomoses during pelvic exenteration for gynaecological malignancy.
    Lim SW; Lim SB; Park JY; Park SY; Choi HS; Jeong SY
    Br J Surg; 2008 Jun; 95(6):770-3. PubMed ID: 18418859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pelvic exenteration in gynecologic oncologic surgery].
    Beretta P; Paoli P; Lombardi PL
    Minerva Ginecol; 1990 Jun; 42(6):267-9. PubMed ID: 2381558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laparoscopy-assisted vaginal pelvic exenteration.
    Ferron G; Querleu D; Martel P; Letourneur B; Soulié M
    Gynecol Oncol; 2006 Mar; 100(3):551-5. PubMed ID: 16249020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Operative mortality and morbidity in pelvic exenteration. Technical aspects].
    De Ranieri J; Crouet H; André M; Souloy J; Desdoits JM; Bouvet A
    J Chir (Paris); 1986 Apr; 123(4):246-50. PubMed ID: 3745309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of 108 exenteration operations in advanced gynecologic cancers].
    Friedberg V
    Geburtshilfe Frauenheilkd; 1989 May; 49(5):423-7. PubMed ID: 2472302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robotic-assisted laparoscopic exenteration in recurrent cervical cancer Robotics improved the surgical experience for 2 women with recurrent cervical cancer.
    Davis MA; Adams S; Eun D; Lee D; Randall TC
    Am J Obstet Gynecol; 2010 Jun; 202(6):663.e1. PubMed ID: 20510970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Exenteration of pelvic organs and its modifications].
    Gotsadze DT
    Vopr Onkol; 1997; 43(6):653-6. PubMed ID: 9479371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pelvic exenteration. Has it a role in 1987? A six year experience.
    Shepherd JH
    Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecologic cancer: Initial results of a phase II trial.
    Martínez-Monge R; Jurado M; Cambeiro M; Valero J; Villafranca E; Alcázar JL
    Brachytherapy; 2006; 5(4):203-10. PubMed ID: 17118310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total pelvic exenteration: results from a multispecialty team approach to complex cancer surgery.
    Ho YH; Cheng C; Tay SK
    Int Surg; 2001; 86(2):107-11. PubMed ID: 11918234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urinary diversion after anterior or total exenteration in advanced tumors of the female genitals].
    Stein R
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):M45-50. PubMed ID: 8682276
    [No Abstract]   [Full Text] [Related]  

  • 33. Pelvic exenteration: an editorial response.
    Sevin BU; Averette HE
    Cancer Invest; 1987; 5(4):377-8. PubMed ID: 3664335
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combined surgical and radiotherapeutic treatment of pelvic wall recurrences: report of experiences after 3 years].
    Höckel M; Knapstein PG; Hohenfellner R; Rösler HP; Kutzner J
    Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):169-76. PubMed ID: 8467983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of body mass index on surgical outcomes and survival following pelvic exenteration.
    Iglesias DA; Westin SN; Rallapalli V; Huang M; Fellman B; Urbauer D; Frumovitz M; Ramirez PT; Soliman PT
    Gynecol Oncol; 2012 May; 125(2):336-42. PubMed ID: 22261299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pelvic exenteration and sphincter preservation: an analysis of 96 cases.
    Poletto AH; Lopes A; Carvalho AL; Ribeiro EA; Vieira RA; Rossi BM; Aguiar S; Guimarães GC; Ferreira Fde O; Nakagawa WT
    J Surg Oncol; 2004 Jun; 86(3):122-7. PubMed ID: 15170649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pelvic exenteration for gynecological malignancies: an analysis of 15 cases operated on at a single institution.
    Mäenpää JU; Kangasniemi K; Luukkaala T
    Acta Obstet Gynecol Scand; 2010; 89(2):279-83. PubMed ID: 19916881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interventions of pelvic evisceration in the treatment of genital cancer in the advanced stage].
    Laureti E; Maggino T
    Minerva Ginecol; 1987 Apr; 39(4):221-4. PubMed ID: 3601194
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of surgery in the management of recurrent gynecologic cancer.
    Hogan WM; Boente MP
    Semin Oncol; 1993 Oct; 20(5):462-72. PubMed ID: 7692604
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.